The effects of Liuwei Dihuang decoction on the differential expression genes in the hippocampus of senescence-accelerated mouse

Chinese Pharmacological Bulletin

Volumn 22, Issue 8, 2006, Pages 921-926

  Cheng, Xiao Rui ^a   Zhou, Wen Xia ^a   Zhang, Yong Xiang ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

cDNA microarray; Cognitive; Liuwei Dihuang decoction (LW); Senescence accelerated mouse

Indexed keywords

ADENOSINE TRIPHOSPHATASE; COMPLEMENTARY DNA; HUPERZINE A; LIUWEIDIHUANG TANG; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; HIPPOCAMPUS; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SENESCENCE; UPREGULATION;

EID: 33750112035     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Allan B D, Fai P H. The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimers disease[J]. Exp Gerontol, 2005, 40:774-83.
2. Morley J E, Banks W BA, Kumar V B, et al. The SAMPS mouse as a model for Alzeimer disease: studies from Saint Louis University[J]. Int Congr Ser, 2004, 1260:23-8.
3. Randy S, Vijaya R, John E M. Cholinergic deficits in the septal-hippocampal pathway of the SAM-P/8 senescence accelerated mouse[J]. Brain Res, 2003, 966:150-6.
4. Poon H F, Castegena A, Farr S A, et al. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain[J]. Neuroscience, 2004, 126:915-26.
5. Poon H F, Farr S A, Thongboonkerd V, et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders[J]. Neurochem Int, 2005, 46(2):159-68.
6. Hsieh M T, Cheng S J, Lin L W et al. The Ameliorating effects of acute and chronic administration of Liuwei Dihuang Wang on learning performance in rodents[J]. Biol Pharmacol Bull, 2003, 26:156-61.
7. Lee K S, Lim B V, Chang H K, et al. Liuweidihuang-tang improves spatial memory function and increases neurogenesis in the dentate gyras in rats[J]. Fitoterapia, 2005, 76:514-9.
8. Cheng Xiao-rui, Zhou Wei-xia, Zhang Yong-xiang, et al. Differential gene expression profiles in the hippocampus of senescence-acceleraced mouse[J]. Neurobiol Aging, 2006, in press.
9. Strausberg R L, Feingold E A, Grouse L H, et al. Generation and initial analysis of more than 15 000 full-length human and mouse cDNA sequences[J]. Proc Natl Acad Sci, 2002, 99:16899-903.
10. Matsushita K, Morrell C N, Cambien B, et al. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor[J]. Cell, 2003, 115(2):139-50.
11. Mimics K, Middleton F A, Marquez A, et al. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex[J]. Neuron, 2000, 28:53-67.
12. Jiang J, Ballinger C A, Wu Y, et al. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation[J]. J Biol Chem, 2001, 276:42938-44.
13. Imai Y, Soda M, Hatakeyama S, et al. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity[J]. Molec Cell, 2002, 10: 55-67.
14. Shimura H, Schwartz D, Gygi S P, et al. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival[J]. J Biol Chem, 2004, 279(6):4869-76.
15. Petrucelli L, Dickson D, Kehoe K, et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation[J]. Hum Mol Genet, 2004, 13(7):703-14.
16. Patterson C. A new gun in town: the U box is an ubiquitin ligase domain[J]. Sci STKE, 2002, 22(116):PE4.
17. Li L, Xin H, Xu X, et al. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription[J]. Mol Cell Biol, 2004, 24(2):856-64.
18. Hoi J S, Cho S, Park S G, et al. Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes[J]. Biochem Biophys Res Commun, 2004, 321(3): 574-83.
19. He B, Bai S, Hnat A T, et al, An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP)[J]. J Biol Chem, 2004, 279(29): 30643-53.
20. Illario M, Cavallo A L, Bayer K U, et al. Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation[J]. J Biol Chem, 2003, 278(46):45101-8.
21. Xing G, Russell S, Hough C, et al. Decreased prefrontal CaMKII alpha mRNA in bipolar illness[J]. Neuroreport, 2002, 13(4):501-5.
22. Wang Y J, Chen G H, Hu X Y, et al. The expression of calcium/calmodulin- dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology[J]. Brain Res, 2005, 1031(1):101-8.
23. Luo Y, Long JM, Lu C, et al. A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78[J]. J Neurochem, 2002, 80(2):354-61.
24. Liang J S, Kim T, Fang S, et al. Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells[J]. J Biol Chem, 2003, 278 (26):23984-8.
25. Anne E, Uta K, Celio A, et al. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease[J]. Biochem Pharmacol, 2003, 66:1627-34.